Local ablation of pulmonary disease is used for unresectable tumors. The advantages of local tumor destruction include selective tissue damage with less immunosuppression and less release of growth factors, minimal treatment morbidity and mortality, lower costs compared to open surgery, and a considerable gain in quality of life. Nevertheless, as the procedure is not free of complications, a careful assessment of risks and benefits has to be made in each patient by a multidisciplinary team.